News: My Cancer Genome

Investigators Win Global GE Research Grants

Tuesday, March 27th, 2012

Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.” The grants were awarded to Jennifer Pietenpol, Ph.D., director of VICC, and the My Cancer Genome project, developed by Mia Levy, M.D., Ph.D., assistant professor of Medicine and Biomedical Informatics, and William Pao, M.D., Ph.D., […]

My Cancer Genome Wins Technology Award

Friday, January 13th, 2012

Vanderbilt-Ingram Cancer Center physician-scientists who created the new online medical decision support tool called “My Cancer Genome” have been named winners of a $20,000 health care technology award sponsored by the National Cancer Institute. The contest, “Using Public Data for Cancer Prevention and Control: From Innovation to Impact Developer Challenge,” was presented as part of […]

MyCancerGenome Finalist for Tech Award

Friday, October 28th, 2011

MyCancerGenome, the online medical decision support tool for cancer care developed by Vanderbilt physician-scientists, has been selected as a finalist for a health care technology award. The contest, “Using Public Data for Cancer Prevention and Control: From Innovation to Impact Developer Challenge,” is sponsored by the National Cancer Institute (NCI), Division of Cancer Control and […]

Celebrate National Cancer Research Month

Monday, May 16th, 2011

May is National Cancer Research Month, and Vanderbilt-Ingram Cancer Center would like to take the opportunity to celebrate the hard work and dedication of scientists and researchers here and around the world. Jennifer A. Pietenpol, Ph.D., the Cancer Center’s director, said celebrating this observance is a way to advocate to the public about the importance […]

Experts Explore Gene Testing Effects

Friday, April 1st, 2011

A mere 10 years after the first draft of the human genome sequence was completed, scientists and companies are delivering some of the first fruits of that achievement to patients and consumers. At Vanderbilt University Medical Center, for example, patients scheduled for cardiac catheterization are tested for a genetic variation to determine which blood thinner […]